ImmunoGen gave a pipeline progress report and 2017 operating results last week. Source: BioSpace

Astellas will gain Universal Cells' proprietary Universal Donor Cell technology to create cell therapy products that do not require HLA matching. Source: BioSpace

The Phase 3 program is the first trial in the JAK1 Atopic Dermatitis Efficacy and Safety global development program. Source: BioSpace

A 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide, a deadly poison, from a Merck facility in Pennsylvania. Source: BioSpace

The company plans to submit for regulatory approvals pending additional data from the ongoing Taltz development program later this year. Source: BioSpace

Teva and Mylan are looking over their shoulders this morning after the FDA gave Novartis and Momenta the green light for their Copaxone copycat drug. Source: BioSpace

The company plans to add approximately 100 positions at the Center by 2020. Source: BioSpace

The FDA approved Vertex's Symdeko for cystic fibrosis in patients ages 12 and older with two copies of the F508del mutation. Source: BioSpace

The acquisition will strengthen Charles River's position as a global early-stage CRO, expanding its client base and service portfolio. Source: BioSpace

Bob Hugin announced his campaign on Monday in an email. Source: BioSpace